Quarantine is an unpleasant experience : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. It may lead to negative mental health consequences and thus the emergence of anxiety and depressive symptoms. From March 17th, 2020 to May 11th 2002, the French government has implemented national containment measures due to the Covid-19 epidemic. Although there are data on the psychological impact and experience of quarantine measures in people who have been infected or suspected of being carriers of certain pathogens (e.g. Ebola), there are no data on such impact in the French population and quarantines lasting longer than 21 days. Investigators therefore propose to conduct a human and social sciences study in order to better understand the current situation
The main objective is to describe the psychological state during confinement (and the impact
of the confinement) in a sample of the French general population.
Secondary objectives :
- to assess the evolution of psychological health between the period of confinement and
post-confinement.
- to identify clinical factors modulating psychological state during confinement
It is expected to highlight :
- a link between the intensity of anxiety symptoms and the number/quality of social
contacts
- a reduction of anxiety and depression symptoms in the post-confinement period.
- higher consumption of drugs during the confinement period
Self-questionnaires (Google form format) are sent by mailing lists or social networks to
participants in order to complete the assessment of psychological state. A unique identifier
is sent in a separate email. These assessments are performed at least once during the
confinement period. It is planned to repeat them when the confinement is lifted: 15 days, 3
and 6 months after the lifting of the confinement because of the risk of developing
anxiodepressive symptoms, in particular post-traumatic stressors.
Other: Slef questionnaires fulfilment
Questionnaires to assess the psychological impact of confinement and its evolution over 6 months
Inclusion criteria:
- age> 18
Exclusion criteria:
- protective measure (curatorship, guardianship)
University hospital
Montpellier, France
Investigator: Catherine Genty, MD
Contact: +33 4 67 99 61 45 75
c-genty@chu-montpellier.fr
Emilie Olie, MD PhD
+33 4 67 33 85 81
e-olie@chu-montpellier.fr
Emilie Olie, MD PhD, Principal Investigator
University Hospital, Montpellier